HBIO·Nasdaq·US
Harvard Bioscience
Harvard Bioscience develops and sells scientific instruments, software, and consumables for life science research, drug discovery, and preclinical testing. Its revenue is primarily derived from laboratory and research equipment sold to academic, biotech, and pharmaceutical customers.
Recent Activity
Updated Oct 10, 2026
–Harvard Bioscience announced the creation of a Scientific Advisory Board.
Past updates are part of the Pro plan.
Thematic Position
Relationship Groups
Relationship details are part of the Pro plan.